Literature DB >> 12435384

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Umit Yasar1, Stefan Lundgren, Erik Eliasson, Anna Bennet, Björn Wiman, Ulf de Faire, Anders Rane.   

Abstract

Cytochrome P450 (CYP) 2C8 and 2C9 are polymorphic enzymes. The CYP2C8*3 and CYP2C9*2 are the major variant alleles in Caucasian populations. The enzymes encoded by these variant alleles have impaired function for the metabolism of several drug substrates. In the present study 1468 subjects that were used as population-based controls in the Stockholm Heart Epidemiology Program (SHEEP) were genotyped by allelic discrimination using a 5'-nuclease assay for CYP2C8*1, 2C8*3, 2C9*1, 2C9*2, and 2C9*3 variant alleles in which the frequencies appeared to be 0.91, 0.095, 0.83, 0.11, and 0.066, respectively. Approximately, 96% of the subjects with CYP2C8*3 allele also carried a CYP2C9*2 and 85% of the subjects that had CYP2C9*2 variant also carried a CYP2C8*3. The number of subjects carrying both of the CYP2C8*1*3 and CYP2C9*1*2 was 4.5-fold higher than expected. This strong association may be of importance especially for the metabolism of common substrates of CYP2C8 and CYP2C9 like arachidonic acid that produces physiologically active metabolites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435384     DOI: 10.1016/s0006-291x(02)02592-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.

Authors:  Tanja Busk Bidstrup; Per Damkier; Anette Kristensen Olsen; Marianne Ekblom; Anders Karlsson; Kim Brøsen
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  CYP2C8 polymorphism frequencies among malaria patients in Zanzibar.

Authors:  I Cavaco; J Strömberg-Nörklit; A Kaneko; M I Msellem; M Dahoma; V L Ribeiro; A Bjorkman; J P Gil
Journal:  Eur J Clin Pharmacol       Date:  2005-01-27       Impact factor: 2.953

Review 3.  Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors:  Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.

Authors:  P Dorado; I Cavaco; M C Cáceres; R Piedade; V Ribeiro; A Llerena
Journal:  Eur J Clin Pharmacol       Date:  2008-06-12       Impact factor: 2.953

5.  Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with KATP channels.

Authors:  Umit Yasar; Melih O Babaoglu
Journal:  Acta Pharmacol Sin       Date:  2018-09-25       Impact factor: 6.150

6.  Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Authors:  Karen Rowland Yeo; Jane R Kenny; Amin Rostami-Hodjegan
Journal:  Eur J Clin Pharmacol       Date:  2013-01-11       Impact factor: 2.953

7.  Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population.

Authors:  Rasmus Steen Pedersen; Mette Marie Hougaard Christensen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2012-04-04       Impact factor: 2.953

8.  Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?

Authors:  Xavier Durrmeyer; Shushanik Hovhannisyan; Yves Médard; Evelyne Jacqz-Aigrain; Fabrice Decobert; Jérome Barre; Corinne Alberti; Yannick Aujard; Claude Danan; Olivier Baud
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

9.  Global variation in CYP2C8-CYP2C9 functional haplotypes.

Authors:  William C Speed; Soonmo Peter Kang; David P Tuck; Lyndsay N Harris; Kenneth K Kidd
Journal:  Pharmacogenomics J       Date:  2009-04-21       Impact factor: 3.550

10.  CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.

Authors:  H Jernström; E Bågeman; C Rose; P-E Jönsson; C Ingvar
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.